DK1196598T3 - DSP-3 phosphatase med dobbelt specificitet - Google Patents

DSP-3 phosphatase med dobbelt specificitet

Info

Publication number
DK1196598T3
DK1196598T3 DK00943359T DK00943359T DK1196598T3 DK 1196598 T3 DK1196598 T3 DK 1196598T3 DK 00943359 T DK00943359 T DK 00943359T DK 00943359 T DK00943359 T DK 00943359T DK 1196598 T3 DK1196598 T3 DK 1196598T3
Authority
DK
Denmark
Prior art keywords
dsp
phosphatase
double specificity
cell
polypeptides
Prior art date
Application number
DK00943359T
Other languages
English (en)
Inventor
Ralf M Luche
Bo Wei
Original Assignee
Ceptyr Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2000/009185 external-priority patent/WO2000060092A2/en
Application filed by Ceptyr Inc filed Critical Ceptyr Inc
Application granted granted Critical
Publication of DK1196598T3 publication Critical patent/DK1196598T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Obesity (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK00943359T 1999-07-02 2000-06-29 DSP-3 phosphatase med dobbelt specificitet DK1196598T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US14233899P 1999-07-02 1999-07-02
PCT/US2000/009185 WO2000060092A2 (en) 1999-04-07 2000-04-07 Dsp-3 dual-specificity phosphatase
PCT/US2000/010868 WO2001002581A1 (en) 1999-07-02 2000-04-20 Dsp-3 dual-specificity phosphatase
PCT/US2000/018207 WO2001002582A1 (en) 1999-07-02 2000-06-29 Dsp-3 dual-specificity phosphatase

Publications (1)

Publication Number Publication Date
DK1196598T3 true DK1196598T3 (da) 2007-04-02

Family

ID=37517972

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00943359T DK1196598T3 (da) 1999-07-02 2000-06-29 DSP-3 phosphatase med dobbelt specificitet

Country Status (9)

Country Link
EP (2) EP1772517A3 (da)
JP (1) JP2003525027A (da)
AT (1) ATE346939T1 (da)
AU (2) AU4367600A (da)
CA (1) CA2377670A1 (da)
DE (1) DE60032145T2 (da)
DK (1) DK1196598T3 (da)
ES (1) ES2277843T3 (da)
WO (2) WO2001002581A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001012819A2 (en) * 1999-08-13 2001-02-22 Sugen, Inc. Protein phosphatases and diagnosis and treatment of phosphatase-related disorders
US6900043B1 (en) 1999-09-21 2005-05-31 Amgen Inc. Phosphatases which activate map kinase pathways
CA2447583A1 (en) * 2001-05-16 2003-03-27 Ceptyr, Inc. Dsp-18 dual-specificity phosphatase
CA2480664A1 (en) * 2002-03-28 2003-10-09 Qlt Inc. Cancer associated protein phosphatases and their uses
CN113801156B (zh) * 2021-10-13 2022-11-15 北京大学 一种蛋白酪氨酸磷酸酶选择性抑制剂、用途、制备方法以及药物组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8479498A (en) * 1997-07-08 1999-02-08 Cold Spring Harbor Laboratory Dual specificity phosphatase and methods of use
WO2000006728A2 (en) * 1998-07-28 2000-02-10 Incyte Pharmaceuticals, Inc. Phosphorylation effectors
WO2000060092A2 (en) * 1999-04-07 2000-10-12 Ceptyr, Inc. Dsp-3 dual-specificity phosphatase
WO2001012819A2 (en) * 1999-08-13 2001-02-22 Sugen, Inc. Protein phosphatases and diagnosis and treatment of phosphatase-related disorders
US6900043B1 (en) * 1999-09-21 2005-05-31 Amgen Inc. Phosphatases which activate map kinase pathways

Also Published As

Publication number Publication date
ATE346939T1 (de) 2006-12-15
EP1196598A1 (en) 2002-04-17
EP1772517A3 (en) 2007-04-18
AU4367600A (en) 2001-01-22
CA2377670A1 (en) 2001-01-11
ES2277843T3 (es) 2007-08-01
EP1196598B1 (en) 2006-11-29
WO2001002581A1 (en) 2001-01-11
DE60032145T2 (de) 2007-10-25
EP1772517A2 (en) 2007-04-11
JP2003525027A (ja) 2003-08-26
AU5783800A (en) 2001-01-22
WO2001002582A1 (en) 2001-01-11
DE60032145D1 (de) 2007-01-11

Similar Documents

Publication Publication Date Title
BR0315688A (pt) Compostos, composições farmacêuticas e seus usos no tratamento ou prevenção de doenças ou condições de proliferação celular metabólicas
UA74325C2 (uk) ГЕТЕРОЦИКЛІЧНІ ІНГІБІТОРИ р38, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЇХ МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ ЗА ЇХ ДОПОМОГОЮ
HK1118210A1 (en) Compositions and methods for treating cardiac conditions
ATE357509T1 (de) Stimulierung von hämatopoietischen zellen im vitro
TR200103428T2 (tr) IMPDH enzim inhibitörleri.
ATE188256T1 (de) Oberflächenlokalisierte expression von enzymen in gengesteuerter prodrugtherapie
ATE296799T1 (de) P38-inhibitoren
DK1226233T3 (da) Multipotente voksne stamceller og fremgangsmåder til isolering heraf
ATE529109T1 (de) Hemmung der p38 kinase aktivität durch substituierte heterocyclische harnstoffe
MY117526A (en) N-(3-benzofuranyl)urea-derivatives
HK1107778A1 (en) Sodium stibogluconate and il-2 for treating cancer
DE59010347D1 (de) Substituierte N-(Chinolin-2-yl-methoxy)benzylsulfonylharnstoffe
BR9913190A (pt) Modulação de proteìnas quinase de linhagemmúltipla
DK1196598T3 (da) DSP-3 phosphatase med dobbelt specificitet
MXPA04001720A (es) Acido nucleicos bv8 y polipeptidos con actividad mitogenica.
WO2000060092A3 (en) Dsp-3 dual-specificity phosphatase
WO2002024740A3 (en) Dsp-15 dual-specificity phosphatase
HUP0301691A2 (hu) Emlőseredetű 2. típusú szfingozin kináz izoalakok, továbbá klónozási, termeltetési és alkalmazási eljárásaik
WO2002026997A3 (en) Dsp-16 dual-specificity phosphatase
WO2001083723A3 (en) Dsp-14 dual-specificity phosphatase
WO2003025196A3 (en) Dsp-18 dual-specificity phosphatase
WO2001057221A3 (en) Dsp-12 and dsp-13 dual-specificity phosphatases
WO2000053636A3 (en) Dsp-1 dual-specificity map kinase phosphatase
BR0113266A (pt) Métodos para modular proteìnas quinase de linhagem múltipla e compostos protetores que modulam proteìnas quinase de linhagem múltipla
DE69932592D1 (de) Rekombinante proteine abgeleitet von hgf und msp